Thursday, October 8, 2026
8:00 AM - 12:00 PM

Pre-Conference Workshop: State-of-the-Art Technologies to Advance the Next Generation of FTD Researchers
1:15 PM - 1:45 PM

Presidential Lecture
Speaker: Olivier Piguet (Australia)
1:30 PM - 1:45 PM

Opening Ceremony
1:45 PM - 3:15 PM

Plenary Session 1 - Update on Clinical Syndromes
1:45 PM - 2:15 PM
Right Temporal Variant FTD
Speaker: Ulugut Hulya (USA)
2:15 PM - 2:45 PM
Lateralized Atrophy and Emotions in FTD
Speaker: Virginia Sturm (USA)
2:45 PM - 3:15 PM
Redefining the ALS-FTD Spectrum: Biological & Clinical Considerations
Speaker: Michael Strong (Canada)
3:15 PM - 3:45 PM

Coffee Break
3:45 PM - 5:15 PM

Abstracts Session 1.1 - Behaviour/Cognition/Language
3:45 PM - 5:15 PM

Abstracts Session 1.2 - Neuropathology
5:15 PM - 7:00 PM

Poster Viewing & Welcome Reception
Friday, October 9, 2026
7:30 AM - 8:30 AM

Industry Sponsored Breakfast Symposium
8:30 AM - 10:00 AM

Plenary Session 2 - Biomarker/Epidemiology
8:30 AM - 9:00 AM
Mapping the Social Exposome and Biomarker Signatures of Frontotemporal Dementia Across Latin America
Speaker: Agustin Ibañez (Chile)
9:00 AM - 9:30 AM
RNA Dysregulation and Cryptic Splicing in TDP-43 Proteinopathy as Biomarker
Speaker: Pietro Fratta (UK)
10:00 AM - 10:30 AM

Coffee Break
10:30 AM - 12:00 PM

Abstracts Session 2 - Biomarker/Imaging
12:00 PM - 1:30 PM

Lunch & Poster Viewing
12:15 PM - 1:15 PM

Industry Sponsored Lunch Symposium
1:30 PM - 3:30 PM

Plenary Session 3 - Update on Genetics and Neuropath of FTD
1:30 PM - 2:00 PM
Structural Classification of FTLD
Speaker: Benjamin Ryskeldi-Falcon (UK)
2:00 PM - 2:30 PM
Genes and Risk Factors for FTLD Subtypes
Speaker: Rosa Rademakers (Belgium)
3:30 PM - 4:00 PM

Coffee Break
4:00 PM - 4:15 PM

Award Ceremony
4:15 PM - 4:45 PM

Holly Hayes Annual Lecture on FTD
Speaker: Susan Dickinson (USA)
More Info
4:45 PM - 5:30 PM

Panel: Recent Advances in Biomarkers and Emerging Therapies Shaping the Research Landscape
5:30 PM - 6:30 PM

ISFTD Business Meeting
Saturday, October 10, 2026
7:30 AM - 8:30 AM

Industry Sponsored Breakfast Symposium
8:30 AM - 10:00 AM

Plenary Session 4 - Clinical Trials/Trial Design
8:30 AM - 9:00 AM
Digital Health Assessments in FTLD
Speaker: Adam Staffaroni (USA)
9:00 AM - 9:30 AM
Update on Tau Targeting Trials in PSP/CBS
Speaker: Günter Höglinger (Germany)
9:30 AM - 10:00 AM
FTD Care/Care Management
Speaker: Lauren Massimo (USA)
10:00 AM - 10:30 AM

Coffee Break
10:30 AM - 12:00 PM

Abstracts Session 3.1 - Genetics
10:30 AM - 12:00 PM

Abstracts Session 3.2 - Behviour/Psychiatry
12:00 PM - 1:30 PM

Lunch & Poster Viewing
12:15 PM - 1:15 PM

Industry Sponsored Lunch Symposium
1:30 PM - 3:00 PM

Abstracts Session 4.1 - Pathomechanism
1:30 PM - 3:00 PM

Abstracts Session 4.2 - Clinical Overlap (MND, Movement)
3:00 PM - 3:30 PM

Coffee Break
3:30 PM - 5:00 PM

Plenary Session 5 - Pathomechanisms and Translation
3:30 PM - 4:00 PM
Modeling of TDP-43 and C9orf72 Related Diseases
Speaker: Clotilde Lagier-Tourenne (USA)
4:00 PM - 4:30 PM
Transynaptic Tau Spread in Tauopathies
Speaker: Tara Spires-Jones (UK)
5:00 PM - 7:00 PM

ISTAART PIA Workshop: Integrating Diversity into Frontotemporal Dementia Research: From Biological Insight to Equitable Clinical Practice
Sunday, October 11, 2026
8:30 AM - 10:00 AM

Plenary Session 6
10:00 AM - 10:30 AM

Prize Ceremony & Closing Remarks